Filing Details

Accession Number:
0001209191-19-048931
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-09 17:45:46
Reporting Period:
2019-09-09
Accepted Time:
2019-09-09 17:45:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337553 Aerie Pharmaceuticals Inc AERI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1252014 J Richard Rubino C/O Aerie Pharmaceuticals, Inc.
4301 Emperor Blvd., Suite 400
Durham NC 27703
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-09 5,040 $19.93 339,446 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.835 to $20.01, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnotes to this Form 4.